Breast Cancer Research

official impact factor 5.79

Review

The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions

Jorge S Reis-Filho1,2 and Sunil R Lakhani1,3*

Author Affiliations

1 The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK

2 Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Braga, Portugal

3 The Royal Marsden Hospital, Fulham Rd, London, UK

For all author emails, please log on.

Breast Cancer Res 2003, 5:313-319 doi:10.1186/bcr650

Published: 9 October 2003

Abstract

The development of modern molecular genetic techniques has allowed breast cancer researchers to clarify the multistep model of breast carcinogenesis. Laser capture microdissection coupled with comparative genomic hybridisation and/or loss-of-heterozygosity methods have confirmed that many pre-invasive lesions of the breast harbour chromosomal abnormalities at loci known to be altered in invasive breast carcinomas. Current data do not provide strong evidence for ductal hyperplasia of usual type as a precursor lesion, although some are monoclonal proliferations; however, atypical hyperplasia and in situ carcinoma appear to be nonobligate precursors. We review current knowledge and the contribution of molecular genetics in the understanding of breast cancer precursors and pre-invasive lesions.

Keywords:
atypical ductal hyperplasia; comparative genomic hybridisation; ductal carcinoma in situ; lobular carcinoma in situ; loss of heterozygosity